Lupin Diagnostics launches its first Regional Reference Laboratory in Patna

15 Jun 2022 , 03:50 PM

Global pharma major Lupin Limited has announced today that Lupin Diagnostics has launched its first Regional Reference Laboratory in Patna, Bihar.

According to the press release, the new Regional Reference Laboratory at Patna has capabilities to conduct a broad spectrum of routine and specialized tests in the fields of molecular diagnostics, cytology, microbiology, serology, haematology, immunology and routine biochemistry.

By establishing a presence in Patna, the company now looks forward to making a deeper foray into Bihar. Earlier this year, Lupin Diagnostics opened its Regional Reference Laboratories in Assam and West Bengal. Through upcoming launches of laboratories in Jharkhand (Ranchi) and Orissa (Bhubaneshwar), the company is poised to solidify its position in East India. Lupin Diagnostics now operates through more than 100 diagnostic centers in East India and close to 280 centers across the country.

Ravindra Kumar, Vice President and Head – Lupin Diagnostics said, “We are pleased to announce the launch of our Regional Reference Laboratory in Patna. Through this we plan to provide quality and affordable testing services for a broad range of routine and specialized tests across the state of Bihar. By leveraging our extensive network of LupiMitra centers, we will make quality diagnostics services available to patients even in the most remote areas.”

Lupin Diagnostics offers a comprehensive range of diagnostics services to doctors, patients and consumers. Some of its key consumer-centric features are GPS-enabled temperature—controlled sample movement, smart reports, free home collection, NABL accreditation of each laboratory, trend report analysis, and live home collection booking and tracking.

The company started its journey by establishing a state-of-the-art 45,000 square foot National Reference Laboratory in Navi Mumbai with world-class equipment, experienced doctors assisted by trained technologists, and stringent quality control protocols.

On Wednesday, Lupin ended at Rs614.45 per share higher by 0.94% on the BSE.